NEC Baby Formula Settlement Amounts 2026: How Much Are Claims Worth?

What NEC Baby Formula Claims Are Projected to Pay

No settlement grid exists yet because no global deal has been struck. What circulates instead are attorney projections built from the injury tiers common to mass torts and from the state-court verdicts already on the record. Those projections cluster into three bands, and the spread between them is the single most important thing a family can understand before signing a contingency-fee agreement.

Plaintiff firms tracking the litigation estimate non-fatal NEC injuries in the $50,000 to $600,000 range, cases involving permanent disability at $1 million to $10 million, and infant-death cases higher still. These are projections, not offers — the manufacturers have agreed to none of them. Understanding how these bands map onto the broader mass tort versus class action distinction matters, because unlike a class action, each NEC plaintiff’s payout is negotiated on individual injury facts rather than divided from a common fund.

Notice what the table does not promise: certainty. The permanent-disability band alone spans a factor of ten. Where a given case lands depends on documented surgery, length of NICU stay, and lasting impairment — the same variables that drive the medical costs examined below.

The Verdict Record: What Juries Have Actually Awarded

Projections are speculation; verdicts are data. Four state-court trials have produced numbers, and they diverge wildly — which is precisely why the manufacturers have resisted settling. A jury in one county sees willful concealment; a jury one state over sees an essential NICU product and clears the defendant entirely.

The largest award remains a July 2024 Missouri verdict of $495 million against Abbott — $95 million compensatory and $400 million punitive — for an NEC death linked to Similac. A Missouri appellate court later affirmed it. In April 2026, a Cook County jury awarded four families $70 million against Abbott, structured as $53 million compensatory plus $17 million punitive after finding Abbott’s conduct willful and wanton. Individual family awards inside that verdict ranged from $7 million to $16 million. But the record cuts both ways: an October 2024 St. Louis jury sided entirely with Abbott and Mead Johnson, and in June 2026 an Illinois appellate court reversed an earlier $60 million verdict against Mead Johnson.

Add the standing plaintiff verdicts and the total exceeds half a billion dollars. Yet not one dollar has been paid to the roughly 810 MDL claimants, because these are outlier state-court results, not settlement benchmarks. As with Roundup lawsuit payout data, a handful of massive verdicts can coexist with defendants refusing to settle the broader inventory for years.

What Determines an NEC Settlement: The Medical-Cost Anchor

Damages in a product-liability case are not conjured from the verdict headlines — they are built upward from documented harm. For NEC, the medical record is unusually expensive, and that expense forms the floor of any serious claim. Consider a representative surgical case to see how the numbers accumulate.

A premature infant develops NEC in the second or third week of life. NEC affects roughly 11% of very-low-birth-weight infants and 22% of extremely-low-birth-weight infants, per the 2026 Frontiers in Pediatrics analysis. Between 44% and 70% of diagnosed neonates progress to advanced (Bell’s stage III) disease requiring surgery, according to a BMC Pediatrics study drawing on Texas Medicaid data. Two studies cited in the journal Pediatrics (American Academy of Pediatrics, 2015) placed the average U.S. charge for a case of surgical NEC at $400,000 to $500,000, with one prospective study finding a range of $300,000 to $660,000. That is the initial hospitalization alone.

Survivors of advanced NEC then face long-term costs: short-bowel syndrome, repeat surgeries, parenteral nutrition, and neurodevelopmental impairment requiring years of therapy and special education. The AAP-published research estimates the national annual economic burden of NEC at $500 million to $1 billion. Stack the initial surgical charge, decades of follow-up care, lost parental wages, and non-economic pain and suffering, and a permanent-disability claim’s documented economic damages can approach seven figures before any punitive component — which is why the disability tier projects into the millions. Families weighing whether pursuing a claim is worthwhile can compare the arithmetic to Camp Lejeune claim case values, another litigation where quantified medical harm anchors individual payouts.

State Court vs. Federal MDL: Which Path Is Better for NEC Plaintiffs?

Here is the divide that defines this litigation. Nearly identical claims are producing opposite results depending on the courtroom, and the reason is procedural, not factual. A plaintiff whose case sits in the federal MDL faces a very different landscape than one whose case proceeds in Illinois or Missouri state court.

State courts have delivered the eye-catching wins — the $495 million and $70 million verdicts both came from state juries. The federal MDL 3026, by contrast, has been brutal for plaintiffs: Abbott won the first three bellwether trials on summary judgment, with Judge Pallmeyer finding plaintiffs failed to present adequate evidence of a feasible safer alternative product or to satisfy the Daubert standard for expert testimony. Meanwhile, the learned-intermediary doctrine — that manufacturers must warn physicians, not parents directly — powered the June 2026 reversal of the $60 million state verdict, signaling that even state wins are vulnerable on appeal. The mechanics of how these coordinated proceedings move through discovery and bellwethers mirror the mass tort case timeline by litigation stage seen in other product cases.

What Most Families Get Wrong About NEC Claim Values

Misreading this litigation is easy, because the advertising leads with nine-figure verdicts and buries the qualifiers. Three mistakes recur, and each can cost a family real money or a valid claim.

Mistake 1: Treating verdicts as settlement values. The consequence is inflated expectations that make a fair settlement feel like a lowball. A $495 million verdict is a statistical outlier from a sympathetic jury, later subject to appeal and reduction. The correct action is to anchor expectations to the projected tiers — $50,000 to $600,000 for non-fatal injury, $1 million to $10 million for permanent disability — and treat verdicts as context, not forecast.

Mistake 2: Assuming a global settlement is imminent. The consequence is passivity — waiting instead of preserving evidence or filing. As of mid-2026 no settlement had been announced, and the hostile federal bellwether record gives manufacturers little reason to rush. The correct action is to build the claim now: secure NICU feeding logs, formula brand and lot records, and abdominal imaging while they remain available.

Mistake 3: Missing the filing deadline. The consequence is total loss of the claim regardless of its merit. Statutes of limitations for NEC claims range from one to six years depending on the state, and in some jurisdictions the clock starts at diagnosis. The correct action is to confirm your state’s specific deadline with an attorney immediately rather than assuming a national deadline applies. Because solicitation in high-value mass torts attracts bad actors, families should also review guidance on verifying mass tort claims and avoiding scams before responding to any unsolicited outreach.

Who Should File — and Is It Worth It?

Not every premature birth with a NEC diagnosis translates into a viable claim, and honest eligibility screening saves families from false hope. The threshold facts are specific.

You likely have a claim worth investigating if your child was born prematurely (generally before 37 weeks), was fed a cow’s-milk-based formula or human-milk fortifier from Similac, Enfamil, or a generic equivalent — typically in a hospital NICU — and was then diagnosed with NEC. Wrongful-death claims apply where an infant died from NEC or its complications. The strength of the claim rises with documented surgery, extended NICU stay, and lasting impairment, because those facts move a case from the lower projected tier toward the disability tier.

Is it worth it? For a family whose child suffered surgical NEC with permanent consequences, the projected six-to-seven-figure range generally justifies pursuing a claim, even after attorney fees. Contingency-fee structures mean no upfront cost, though families should understand how the mass tort attorney fee structure and net recovery reduces the gross figure — a typical contingency fee plus case expenses can consume 33% to 40% or more of a recovery. For a mild, fully recovered non-fatal case in the lowest tier, the math is closer, and the deduction of fees and costs matters more. The determinative variable is documented severity. Families uncertain where their case falls should get a specific injury assessment rather than relying on the ranges here, which describe the litigation as a whole rather than any individual claim. Those comparing this to other pediatric or consumer-product torts may also weigh the eligibility logic behind social media addiction lawsuit claims, where injury documentation similarly governs case value.

How We Researched This Article

This report synthesizes three categories of primary and analytical sources: court and litigation records, peer-reviewed medical cost and epidemiology research, and attorney-published settlement projections. Case counts and verdict figures were drawn from litigation trackers reporting Judicial Panel on Multidistrict Litigation docket data for MDL 3026 and from contemporaneous trial and appellate reporting, cross-checked across multiple independent trackers to confirm the April 2026 Cook County verdict structure ($53 million compensatory plus $17 million punitive) and the June 2026 Illinois Fifth District appellate reversal of the $60 million Mead Johnson verdict on learned-intermediary grounds.

Medical cost and epidemiology figures were sourced from peer-reviewed literature indexed by the National Institutes of Health, including a 2026 Frontiers in Pediatrics analysis using CDC WONDER mortality data, a surgical-cost study published in Pediatrics by the American Academy of Pediatrics, and a Texas Medicaid longitudinal cost study in BMC Pediatrics via the NIH PubMed Central archive. Clinical staging and incidence data were verified against NIH StatPearls.

Settlement ranges are explicitly modeled projections published by plaintiff firms, not measured settlement values, and are labeled as such throughout because no global NEC settlement existed at publication. Verdict amounts are measured court outcomes. The distinction between modeled projections and measured verdicts is maintained in every table and section. Limitations: settlement projections are inherently speculative and firm-dependent; medical cost studies reflect the publication years cited inline and may understate current charges; and litigation status changes rapidly. This research was last conducted in August 2026. All figures were verified against named primary sources before publication.